Tarsus Pharmaceuticals, Inc. Quarterly Marketable Securities, Current in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Tarsus Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q2 2024.
  • Tarsus Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $142M, a 99.4% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $142M +$71M +99.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $105M -$30.4M -22.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.5M -$143M -98.3% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $20.2M -$36.9M -64.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $71.5M +$71.5M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $135M +$135M +46368% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $145M +$145M +29996% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $57.1M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $291K Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $483K +$483K Dec 31, 2021 10-K 2023-03-17
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.